Assessment of the types of catheter infectivity caused by Candida species and their biofilm formation. First study in an intensive care unit in Algeria

International Journal of General Medicine

Volumn 6, Issue , 2013, Pages 1-7

  Seddiki, Sidi Mohammed Lahbib ^a   Boucherit Otmani, Zahia ^a   Boucherit, Kebir ^a   Badsi Amir, Souad ^b   Taleb, Mourad ^b   Kunkel, Dennis ^c  

^a UNIVERSITY OF TLEMCEN   (Algeria)

^b Service d'anatomie pathologique   (Algeria)

^c Dennis Kunkel Microscopy Inc   (United States)

Author keywords

Colonization; Contamination; ICU; Infection

Indexed keywords

ACICLOVIR; AMPICILLIN; CEFAZOLIN; CEFOTAXIME; CIPROFLOXACIN; GENTAMICIN; OXACILLIN;

ADULT; AGED; ALGERIA; ARTICLE; BIOFILM; CANDIDA ALBICANS; CANDIDA GLABRATA; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; FEMALE; FUNGAL COLONIZATION; FUNGAL CONTAMINATION; FUNGAL VIRULENCE; HUMAN; INTENSIVE CARE UNIT; MALE; MEDICAL PHOTOGRAPHY; PERIPHERAL VENOUS CATHETER; SCANNING ELECTRON MICROSCOPY; SPECIES IDENTIFICATION; TONGUE; UNIVERSITY HOSPITAL; YEAST CELL;

EID: 84874753332     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S38065     Document Type: Article

References (53)

1. Vandijck D, Blot S, Labeau S, et al. Candidemia in critically ill patients: An analysis of daily antifungal therapy related costs. J Mycol Med. 2008;18(2):96-99.
2. Falagas ME, Roussos N, Vardakas KZ. Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis. 2010;14(11):e954-e966.
3. Eloy O, Marque S, Mourvilliers B, et al. Contribution of the Pittet's index, antigen assay, IgM, and total antibodies in the diagnosis of invasive candidiasis in intensive care unit. J Mycol Med. 2006;16(3):113-118.
4. Eggimann P, Pittet D. Candidoses en réanimation [Candidiasis in the ICU]. Réanimation. 2002;11:209-221. French.
5. Seabra R, Bhogal N. Hospital infections, animal models and alternatives. Eur J Clin Microbiol Infect Dis. 2009;28(6):561-568.
6. Develoux M, Bretagne S. Candidiasis and yeast infections. EMC-Maladies Infectieuses. 2005;2(3):119-139.
7. Gürcüoǧlu E, Akali{dotless}n H, Ener B, et al. Nosocomial candidemia in adults: Risk and prognostic factors. J Mycol Med. 2010;20(4):269-278.
8. Maknia F, Sellamia A, Trabelsi H, et al. Yeast species isolated in the CHU of Sfax, Tunisia. J Mycol Med. 2010;20(1):42-47.
9. Moran C, Grussemeyer CA, Spalding JR, Benjamin DK Jr, Reed SD. Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections. Am J Infect Control. 2010;38(1):78-80.
10. Ruan SY, Lee LN, Jerng JS, Yu CJ, Hsueh PR. Candida glabrata fungaemia in intensive care units. Clin Microbiol Infect. 2008;14(2):136-140.
11. Avila-Aguero ML, Canas-Coto A, Ulloa-Gutierrez R, Caro MA, Alfaro B, Paris MM. Risk factors for Candida infections in a neonatal intensive care unit in Costa Rica. Int J Infect Dis. 2005;9(2):90-95.
12. Picazo JJ, González-Romo F, Candel FJ. Candidemia in the critically ill patient. Int J Antimicrob Agents. 2008;32 Suppl 2:S83-S85.
13. Ramage G, Saville SP, Thomas DP, López-Ribot JL. Candida biofilms: an update. Eukaryotic Cell. 2005;4(4):633-638.
14. Khan S, Alam F, Azam A, Khan AU. Gold nanoparticles enhance methylene blue-induced photodynamic therapy: a novel therapeutic approach to inhibit Candida albicans biofilm. Intl J Nanomedicine. 2012;7:3245-3257.
15. Boucherit-Atmani Z, Seddiki SML, Boucherit K, Sari-Belkharoubi L, Kunkel D. Candida albicans biofilms formed into catheters and probes and their resistance to amphotericin B. J Mycol Med. 2011;21(3):182-187.
16. Soni N, Wagstaff A. Fungal infection. Curr Anaesth Crit Care. 2005;16(4):231-241.
17. Veyssier P, Domart Y, Liebbe AM. Infections Nosocomiales [Nosocomial Infections], 2nded. Paris: Collection Abrégés de Médecine; 1998. French.
18. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg. 1994;220(6):751-758.
19. Carrière C, Marchandin H. Infections liées aux cathéters veineux centraux: diagnostic et definitions [Infection linked to central venous catheters: diagnosis and definitions]. Néphrologie. 2001;22(8):433-437. French.
20. Timsit JF, Wolff M, Mourvillier B, Schortgen F, Régnier B. Diagnosis and management of catheter-related infections in the ICU. Méd Mal Infect. 2003;33(12):619-627.
21. Gallien S, Sordet F, Enache-Angoulvant A. Treatment of catheter-related candidemia. J Mycol Med. 2007;17(1):42-49.
22. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med. 2002;113(6):480-485.
23. Kadir T, Pisiriciler R, Akyüz S, Yarat A, Emekli N, Ipbüker A. Mycological and cytological examination of oral candidal carriage in diabetic patients and non-diabetic control subjects: thorough analysis of local aetiologic and systemic factors. J Oral Rehabil. 2002;29(5):452-457.
24. Brun-Buisson C, Abrouk F, Legrand P, Huet Y, Larabi S, Rapin M. Diagnosis of central venous catheter-related sepsis: Critical level of quantitative tip cultures. Arch Intern Med. 1987;147(5):873-877.
25. Chandra J, Mukherjee PK, Ghannoum MA. In vitro growth and analysis of Candida biofilms. Nat Protoc. 2008;3(12):1909-1924.
26. Timsit JF, Dubois Y, Minet C, et al. New materials and devices for preventing catheter-related infections. Ann Intensive Care. 2011;1:34.
27. Almirante B, Rodríguez D, Park BJ, et al; Barcelona Candidemia Project Study Group. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 2005;43(4):1829-1835.
28. Kettani A, Belkhadir ZH, Mosadik A, et al. Antifungal treatment of systemic candidiasis in intensive care unit. J Mycol Med. 2006;16(1):16-25.
29. Chalmers CM, Bal AM. Management of fungal infections in the intensive care unit: a survey of UK practice. Br J Anaesth. 2011;106(6):827-831.
30. Clark TA, Hajjeh RA. Recent trends in the epidemiology of invasive mycoses. Curr Opin Infect Dis. 2002;15(6):569-574.
31. Fidel PL Jr, Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev. 1999;12(1):80-96.
32. Ruan SY, Huang YT, Chu CC, Yu CJ, Hsueh PR. Candida glabrata fungaemia in a tertiary centre in Taiwan: antifungal susceptibility and outcomes. Int J Antimicrob Agents. 2009;34(3):236-239.
33. Hajjeh RA, Sofair AN, Harrison LH, et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000in a population-based active surveillance program. J Clin Microbiol. 2004;42(4):1519-1527.
34. Tortorano AM, Caspani L, Rigoni AL, Biraghi E, Sicignano A, Viviani MA. Candidiasis in the intensive care unit: a 20-year survey. J Hosp Infect. 2004;57(1):8-13.
35. Pfaller MA, Messer SA, Hollis RJ, et al. Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. Diagn Microbiol Infect Dis. 1999;33(4):217-222.
36. Klevay MJ, Ernst EJ, Hollanbaugh JL, Miller JG, Pfaller MA, Diekema DJ. Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection. Diagn Microbiol Infect Dis. 2008;60(3):273-277.
37. Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP; National Nosocomial Infections Surveillance System Hospitals. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis. 2002;35(5):627-630.
38. Verstrepen KJ, Reynolds TB, Fink GR. Origins of variation in the fungal cell surface. Nat Rev Microbiol. 2004;2(7):533-540.
39. Bleichner G, Beaucaire G, Gottot S, et al. Infections liées aux cathéters veineux centraux en reanimation [Infections related to central venous catheters in intensive care]. Réan Urg. 1994;3:321-330. French.
40. Abbes S, Sellami H, Sellami A, et al. Variability of Candida albicans strains in ICU in Tunisia hospital. J Mycol Med. 2008;18(1):10-15.
41. Bouza E, Muñoz P. Epidemiology of candidemia in intensive care units; Int J Antimicrob Agents. 2008;32 Suppl 2:S87-S91.
42. Nairy HM, Charyulu NR, Shetty VA, Prabhakara P. A pseudo-randomised clinical trial of in situ gels of fluconazole for the treatment of oropharngeal candidiasis. Trials. 2011;12:99.
43. Hoshi N, Mori H, Taguchi H, et al. Management of oral candidiasis in denture wearers. J Prosthodont Res. 2011;55(1):48-52.
44. Yang YL, Lo HJ, Hung CC, Li Y. Effect of prolonged HAART on oral colonization with Candida and candidiasis. BMC Infect Dis. 2006;6:8.
45. Javed F, Klingspor L, Sundin U, Altamash M, Klinge B, Engström PE. Periodontal conditions, oral Candida albicans and salivary proteins in type 2 diabetic subjects with emphasis on gender. BMC Oral Health. 2009;9:12.
46. Thein ZM, Samaranayake YH, Samaranayake LP. Characteristics of dual species Candida biofilms on denture acrylic surfaces. Arch Oral Biol. 2007;52(12):1200-1208.
47. Mukherjee PK, Chandra J. Candida biofilm resistance. Drug Resist Updat. 2004;7(4-5):301-309.
48. Ha JF, Italiano CM, Heath CH, Shih S, Rea S, Wood FM. Candidemia and invasive candidiasis: a review of the literature for the burns surgeon. Burns. 2011;37(2):181-195.
49. Andes D, Nett J, Oschel P, Albrecht R, Marchillo K, Pitula A. Development and Characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Immun. 2004;72(10):6023-6031.
50. Hawser SP, Douglas LJ. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun. 1994;62(3):915-921.
51. Douglas LJ. Medical importance of biofilms in Candida infections. Rev Iberoam Micol. 2002;19(3):139-143.
52. Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol. 2003;11(1):30-36.
53. Nett JE, Sanchez H, Cain MT, Ross KM, Andes DR. Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation. Eukaryotic Cell. 2011;10(12):1660-1669.